Investigations

GRABAR LAW OFFICE INVESTIGATES CLAIMS AGAINST OFFICERS AND DIRECTORS OF MACROGENICS, INC. (NASDAQ: MGNX)

MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer.

A recently filed securities fraud alleges that MacroGenics, Inc. (NASDAQ: MGNX), via certain of its officers and directors made material misrepresentations about the safety data from its TAMARACK Phase 2 study of vobramitamab duocarmazine. The Complaint further alleges that when on May 9, 2024, the investing public learned that the drug was significantly more dangerous than Defendants had previously represented, MGNX’s stock declined 77.4% due to a drop of $11.36/share, damaging shareholders.

Current MacroGenics shareholders who have held MacroGenics stock since prior to March 7, 2024, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever.

If you would like to learn more about this matter, you are encouraged to contact us at [email protected], or call 267-507-6085.

Attorney Advertising Disclaimer

Join This Action
Name*
First Last
Email Address*
Address*
Street Address City State / Province / Region ZIP / Postal Code
Phone*
Stock Name or Ticker
Number of Shares Purchased
Date(s) Shares Purchased
Purchase Price Per Share
Number of Shares Sold
Date(s) Shares Sold
Sale Price Per Share
Comments
Alternatively, you may upload your transactions using the upload button below or email them to [email protected]. *
File
Drop files here or

Max. file size: 100 MB.
Consent*
By signing and clicking the Submit button below, I hereby execute the Retention Agreement and, upon execution of the Retention Agreement by Grabar Law Office, retain Grabar Law Office to make a demand and bring any ensuing lawsuit on my behalf pursuant to the terms set forth in the Retention Agreement, which is incorporated herein by reference.*
Please sign below using your mouse or touch-pad.*
Signed pursuant to California Civil Code Section 1633.1, et seq. and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.
Date of signing: *
Date of Signing:*
MM slash DD slash YYYY
Phone
This field is for validation purposes and should be left unchanged.

Investigations

GRABAR LAW OFFICE INVESTIGATES CLAIMS AGAINST OFFICERS AND DIRECTORS OF MACROGENICS, INC. (NASDAQ: MGNX)

Join This Action